Skip to content

Retatrutide Waitlist

Retatrutide. Coming Soon

Be the first to know when Retatrutide becomes available for research. Join our priority notification list.

You're on the list! We'll notify you as soon as this product is available.
About Retatrutide Retatrutide (LY-3437943) is a triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Published research has examined it in metabolic models. Available for research use only when this product launches.